S'abonner

A randomized controlled clinical trial to compare the clinical outcome of random-based versus formula-based blood transfusion in a tertiary care hospital setting - 12/03/25

Doi : 10.1016/j.tracli.2025.02.004 
Prashant Pandey a, e, Supriya Kumari a, e, Gyanendra Agarwal b, e, Shalendra Goel b, e, Divya Setya c, e, Saikat Mandal a, d, e, , Arghyadeep Marik a, e, Mukesh Kumar Singh a, e
a Department of Transfusion Medicine & Transplant Immunology, Jaypee Hospital, Sector- 128, Noida 201304, India 
b Department of Respiratory & Critical Care Medicine, Jaypee Hospital, Sector- 128, Noida 201304, India 
c Department of Immunohematology & Transfusion Medicine, Manipal Hospital, Sector- 5, Jaipur 302013, India 
d Centre for Biomedicine, Hull York Medical School, University of Hull, Hull HU6 7RX, United Kingdom 
e Translational Medical Sciences, School of Medicine, University of Nottingham, United Kingdom 

Corresponding author at: Clinical Research Fellow, Room - W/E 1377, Nottingham Digestive Diseases Centre, E Floor, West Block, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH United Kingdom.Clinical Research FellowRoom - W/E 1377Nottingham Digestive Diseases Centre, E FloorWest BlockQueen’sMedical CentreUniversity of NottinghamNottinghamNG7 2UHUnited Kingdom
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 12 March 2025

Highlights

Formula-based blood transfusion had an edge over random-Based transfusion, providing significantly higher increase in post-transfusion hemoglobin (Hb) and hematocrit (Hct).
Based on our results it may be beneficial to implement formula-based blood transfusion in day-to-day blood transfusion practice.

Le texte complet de cet article est disponible en PDF.

Abstract

Background and objectives

Red cell transfusion is the mainstay of therapy for anemia and it is important to transfuse adequate dosage of red cells to maintain tissue oxygen demands. Additionally, it is also important to avoid overload of red cells to prevent adverse effects. Therefore, we compared the rise in hemoglobin and hematocrit for random-Based transfusion (RBT) and formula-based blood transfusion (FBBT) among patients to get a better understanding of differences in clinical outcome between the two methods.

Materials and methods

In this study 752 patients were included who were admitted in the hospital and required transfusion of a single unit of PRBC. Patients included in the study were randomized in two categories, RBT and FBBT, using stratified random sampling without any bias. In RBT category, patients received blood transfusion according to standard practice i.e. patient received the full red cell unit without any modifications in volume. All odd number request in cross-match register during the study period who fulfilled the eligibility were included in this group. In FBBT group, even numbered requests in the crossmatch register were randomized to receive FBBT. In this category, patients received transfusion according to the following formula:

Volume of PRBCs to be transfused = TBV × (Desired Hct − Current Hct of patient)/ Hct of donor unit (where the desired rise of Hct is 3%).

Results

In our study we found that the rise in hemoglobin and hematocrit levels were significantly higher for patients receiving FBBT as compared to the patients receiving RBT. Pre-transfusion hemoglobin and hematocrit did not have a significant difference whereas the post transfusion hemoglobin and hematocrit showed a higher rise in the FBBT group as compared to the RBT group. (Welch corrected t = 2.633, p value = 0.0086).

Conclusion

This study re-emphasizes the value of FBBT over the routinely used RBT. This study found that FBBT had an edge over RBT, providing significantly higher increase in post-transfusion Hb and Hct. The authors therefore are of the opinion that use of FBBT may be considered in routine clinical practice to optimize transfusions for the patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Red cell transfusion, Formula-based transfusion, Random-based transfusion, Weight-based transfusion


Plan


© 2025  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.